Thomas Nee
Investitore di Private Equity presso Larchmont Ventures
Profilo
Mr. Nee is an Operating Partner at Hildred, where he advises on commercial strategy and research across portfolio companies and investment opportunities.
Mr. Nee previously served in a similar operating role at Hildred Capital Partners leveraging his depth of experience to enhance strategic positioning, operational efficiency, and overall growth trajectory.
Mr. Nee is a member of the steering and screening committee of the Mid-Atlantic Bioangels, an angel investor group focused exclusively on new and emerging life science companies.
Mr. Nee has over 25 years experience in biopharmaceuticals and healthcare product marketing.
Mr. Nee previously served as Senior Vice President, Business Analytics & Operations at Allergan overseeing a diverse range of services including commercial deal evaluation, omni-channel marketing, market research.
Mr. Nee served in similar capacities at Forest Laboratories in addition to leadership roles in product management.
Prior to joining Forest, Mr. Nee served in Health & Personal Care brand management at Procter & Gamble.
Mr. Nee provides volunteer leadership with the national governing body of competitive cycling as chairperson of their Technical Commission and Cyclocross Sports Committee.
Mr. Nee has a M.B.A.
from Stanford Graduate School of Business and is an Aresty Scholar at The Wharton School.
Posizioni attive di Thomas Nee
| Società | Posizione | Inizio |
|---|---|---|
| Larchmont Ventures | Investitore di Private Equity | 01/01/2016 |
Hildred Capital Management LLC
 Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Investitore di Private Equity | - |
Precedenti posizioni note di Thomas Nee
| Società | Posizione | Fine |
|---|---|---|
| ALLERGAN PLC | Investitore di Private Equity | 31/12/2016 |
| FOREST LABORATORIES, INC. | Investitore di Private Equity | 31/12/2014 |
Formazione di Thomas Nee
| Santa Clara University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Hildred Capital Management LLC
Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Finance |
| Larchmont Ventures |
- Borsa valori
- Insiders
- Thomas Nee
